(Q52931068)

9 May 2018

title

Perception of quality of life by patients, partners and treating physicians. (English)

1 reference

9 May 2018

0 references

1 reference

4

I F Tannock

1 reference

9 May 2018

author name string

K A Wilson

series ordinal

1

1 reference

9 May 2018

A J Dowling

series ordinal

2

1 reference

9 May 2018

M Abdolell

series ordinal

3

1 reference

9 May 2018

publication date

1 January 2000

1 reference

9 May 2018

published in

Quality of Life Research

1 reference

9 May 2018

volume

9

1 reference

9 May 2018

issue

9

1 reference

9 May 2018

page(s)

1041-1052

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1023/a:1016647407161

exact match

0 references

cites work

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

The Intraclass Correlation Coefficient as a Measure of Reliability

1 reference

12 December 2020

Observer variation in assessment of quality of life in patients with oesophageal cancer.

1 reference

12 December 2020

Reproducibility along a 10 cm vertical visual analogue scale

1 reference

12 December 2020

Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. E

1 reference

12 December 2020

Correlation of patient and caregiver ratings of cancer pain.

1 reference

12 December 2020

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

12 December 2020

The validity of proxy-generated scores as measures of patient health status.

1 reference

12 December 2020

Using proxies to evaluate quality of life. Can they provide valid information about patients' health status and satisfaction with medical care?

1 reference

12 December 2020

Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Re

1 reference

12 December 2020

Agreement between self reports and proxy reports of quality of life in epilepsy patients.

1 reference

12 December 2020

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

12 December 2020

The use of significant others as proxy raters of the quality of life of patients with brain cancer

1 reference

12 December 2020

Reliability of the next of kins' estimates of critically ill patients' quality of life.

1 reference

12 December 2020

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

1 reference

12 December 2020

Quality of life in cancer patients. Who measures what?

1 reference

12 December 2020

Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group

1 reference

12 December 2020

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

12 December 2020

A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology

1 reference

12 December 2020

Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

1 reference

12 December 2020

The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review

1 reference

12 December 2020

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

12 December 2020

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

1 reference

12 December 2020

The use of next-of-kin to estimate pain in cancer patients

1 reference

12 December 2020

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

12 December 2020

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

1 reference

12 December 2020

Value of caregiver ratings in evaluating the quality of life of patients with cancer.

1 reference

12 December 2020

Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand

1 reference

12 December 2020

Evaluation of quality of life in patients receiving treatment for advanced breast cancer

1 reference

12 December 2020

Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials.

1 reference

12 December 2020

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

12 December 2020

Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased?

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016647407161

1 reference

9 May 2018

Dimensions Publication ID

0 references

1 reference

9 May 2018